1
ChadiN, etal. BMJ Paediatrics Open 2020;4:e000840. doi:10.1136/bmjpo-2020-000840
Open access
Vaping- related injury and illness
among Canadian children and
adolescents: a one- time survey of
paediatric providers
Nicholas Chadi ,
1
Charlotte Moore- Hepburn,
2
Suzanne Beno,
3
Sarah A Richmond
4
To cite: ChadiN,
Moore- HepburnC, BenoS, etal.
Vaping- related injury and illness
among Canadian children
and adolescents: a one- time
survey of paediatric providers.
BMJ Paediatrics Open
2020;4:e000840. doi:10.1136/
bmjpo-2020-000840
Received 12 August 2020
Accepted 3 October 2020
1
Division of Adolescent
Medicine, Department of
Paediatrics, Sainte- Justine
University Hospital Centre,
Montreal, Québec, Canada
2
Division of Paediatric Medicine,
Department of Paediatrics,
The Hospital for Sick Children,
Toronto, Ontario, Canada
3
Division of Emergency
Medicine, Department of
Paediatrics, The Hospital for
Sick Children, Toronto, Ontario,
Canada
4
Dalla Lana School of Public
Health, University of Toronto,
Toronto, Ontario, Canada
Correspondence to
Dr Nicholas Chadi; nicholas.
chadi@ umontreal. ca
Original research letter
© Author(s) (or their
employer(s)) 2020. Re- use
permitted under CC BY- NC. No
commercial re- use. See rights
and permissions. Published by
BMJ.
ABSTRACT
A one- time survey distributed to 2693 Canadian
paediatricians enrolled in the Canadian Paediatric
Surveillance Programme was conducted between
October and December 2019. We identied a wide range
of severe vaping- related injuries and illnesses among
children ages 0–17 (n=88), which were associated with
the routine use or malfunctioning of a vaping device or
the ingestion of vaping substances. The most common
clinical presentations were acute respiratory symptoms
and nicotine toxicity and 15% (n=13) of injuries required
intensive care unit admission. Our study highlights the
urgent need for substantive policy measures to help
protect youth against the risks associated with vaping
products.
Recent increases in rates of vaping and
exposure to vaping devices
1
have resulted
in an increase in vaping- related injuries and
illnesses, often in youth.
2
Yet, knowledge
about the incidence, characteristics and
circumstances of these events among chil-
dren and adolescents remains limited.
All practising paediatricians and paediatric
subspecialists (n=2693) participating in the
Canadian Paediatric Surveillance Programme
(CPSP), representing approximately 95% of
practising paediatric providers in Canada,
were invited to complete a one- time online
or paper survey
3
between October and
December 2019. Participants were asked to
provide case- level data for patients under 18
years of age who sought medical attention in
the past 12 months for serious illnesses and/
or injuries related to one of three mecha-
nisms: (1) routine use of a vaping product,
(2) ingestion of vaping substances and (3)
malfunction of a vaping device. Descriptive,
aggregate data are reported as requested by
CPSP policy stating that case numbers and
data elements for fewer than five cases cannot
be presented (to maintain confidentiality).
There was no patient or public involvement
in this study.
The survey response rate was 42%
(1131/2693) and included respondents from
all Canadian provinces and territories. Of the
88 reported cases, there were 13 cases related
to the ingestion of vaping substances, and the
remainder were related to the routine use or
malfunctioning of a vaping device (table 1).
Forty- eight cases (55%) were male, and two-
thirds (n=58, 66%) occurred in adolescents
aged 15–17 years old. The most common
presentation was respiratory distress/lung
injury (n=39, 44%). Twenty- two cases (25%)
were treated on a hospital ward; 13 cases
(15%) required intensive care unit admis-
sion. Harms associated with ingestion of
vaping products included nicotine toxicity,
abdominal pain and nausea/vomiting.
Our survey identified a broad range of
serious vaping- related injuries and illnesses.
Injuries from routine use of a vaping device
and resulting in respiratory distress or lung
injury were the most common, and several
cases required admission to a hospital ward
or intensive care unit.
In 2019, 31.7% of Canadian high- school
students reported vaping in the past 30 days.
1
Initially presented as a less harmful alterna-
tive for adult smokers, vaping products are
now more commonly used by youth—many
of whom have never used tobacco prod-
ucts.
4
Over 2800 hospitalised cases of vaping-
associated lung injury (VALI) were reported
between August 2019 and February 2020 in
the USA, 15% of whom were adolescents ages
13–17 years.
2
In Canada, only 19 cases (5 cases
under age 20) had been publicly reported
by March 2020.
5
Our survey, which includes
cases of vaping- related injuries that presented
before the term VALI was defined, suggests
that acute lung injuries only represent a
on August 2, 2024 by guest. Protected by copyright.http://bmjpaedsopen.bmj.com/bmjpo: first published as 10.1136/bmjpo-2020-000840 on 19 October 2020. Downloaded from
2
ChadiN, etal. BMJ Paediatrics Open 2020;4:e000840. doi:10.1136/bmjpo-2020-000840
Open access
subset of acute vaping- related harms seen in children
and adolescents.
Legislative and policy changes limiting youth access to
vaping products are at different stages of implementation
worldwide. Nonetheless, in most parts of Europe and
North America, vaping products remain easily accessible,
even for underage youth.
6
The 13 cases requiring inten-
sive care admission captured by our survey emphasise the
health burden associated with vaping- related injuries.
Our study has limitations. Survey participants only
included paediatric providers; therefore, results do not
include cases managed by non- paediatricians. In addi-
tion, data collection relied on voluntary reporting which
resulted in a low- to- moderate response rate (42%) subject
to non- response bias and recall bias given the 12- month
reporting period.
Our study provides key insights about acute harms
associated with vaping product exposure among children
and adolescents. These insights highlight the urgent
need for substantive policy measures to help mitigate the
risks associated with vaping products.
Twitter Nicholas Chadi @nicholaschadi and Sarah A Richmond @Sarah_A_
Richmond
Acknowledgements The study team would like to thank the paediatricians and
paediatric subspecialists who participated in this study.
Contributors NC participated in the conceptualisation and design of the study,
conducted data analyses and drafted the initial manuscript. CM- H, SB and SAR
critically reviewed the manuscript for important intellectual content. All authors
participated in the conceptualisation and design of the study, in data interpretation
and approved the nal manuscript as submitted and agree to be accountable for all
aspects of the work.
Funding This study was supported by the Canadian Paediatric Surveillance
Program a joint program of the Canadian Paediatric Society and the Public Health
Agency of Canada. The Canadian Paediatric Surveillance Program supported the
design and conduct of the study as well as collection and management of the data.
Disclaimer The funders had no role in the analysis, and interpretation of the data;
preparation, review or approval of the manuscript; and decision to submit the
manuscript for publication.
Competing interests No, there are no competing interests.
Patient and public involvement Patients and/or the public were not involved in
the design, or conduct, or reporting, or dissemination plans of this research.
Patient consent for publication Not required.
Ethics approval This study was exempt from research ethics approval as a public
health surveillance project collecting only aggregate and anonymous data.
Provenance and peer review Not commissioned; externally peer reviewed.
Open access This is an open access article distributed in accordance with the
Creative Commons Attribution Non Commercial (CC BY- NC 4.0) license, which
permits others to distribute, remix, adapt, build upon this work non- commercially,
and license their derivative works on different terms, provided the original work is
properly cited, appropriate credit is given, any changes made indicated, and the
use is non- commercial. See:http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
ORCID iD
NicholasChadi http:// orcid. org/ 0000- 0003- 1033- 2327
REFERENCES
1 Propel Centre for Population Health Impact. Summary of results for
the Canadian Student Tobacco, Alcohol and Drugs Survey 2018-19
- Canada. ca, 2019. Available: https://www. canada. ca/ en/ health-
canada/ services/ canadian- student- tobacco- alcohol- drugs- survey/
2018- 2019- summary. html [Accessed 23 Aug 2020].
Table 1 Characteristics of children and adolescents with
vaping- related injuries or illnesses
Female Male Total
Total 40 48 88*
Age range (years)
1–14 12 18 30
15–17 28 30 58
Injury mechanism
Routine use of vaping device
or device malfunction
32 43 75
Ingestion of vaping product† 8 5 13
Substance‡
Flavouring 9 13 22
Nicotine 14 19 33
Cannabis 6 15 21
Unknown 17 16 33
No response 5 7 12
Clinical presentation‡
Respiratory distress/lung
injury
22 17 39
Mouth or throat irritation and/
or burn
* 6
Abdominal pain/nausea/
vomiting
* * 9
Symptoms of nicotine toxicity
(other than nausea/vomiting)
* * 15
Central nervous system
depression/altered mental
status
* * 9
Other¶ * * 13
No response 6 7 13
Treatment location‡
Walk- in/outpatient clinic 7 8 15
Emergency department 10 18 28
Hospital ward 10 12 22
Intensive care unit** * * 13
Referred to specialist * * 5
No response 10 13 23
Patient outcome
Full recovery 16 19 35
Ongoing health issues 9 7 16
Unknown 5 8 13
No response 10 14 24
*There were no duplicate cases.
†Fewer than ve cases of injuries caused by the ingestion of a
vaping product required intensive care unit admission.
‡Respondents could select more than one option.
§Asterisk indicates that one or both sex subgroup cells contain
fewer than ve participants (exact number may not be disclosed
due to condentiality concerns).
¶Other symptoms included: injury to upper limbs or torso, head
or neck burn, eye injury/vision loss, and other (unspecied).
**Of the cases requiring intensive care unit admission, fewer
than ve had ongoing health issues.
on August 2, 2024 by guest. Protected by copyright.http://bmjpaedsopen.bmj.com/bmjpo: first published as 10.1136/bmjpo-2020-000840 on 19 October 2020. Downloaded from
3
ChadiN, etal. BMJ Paediatrics Open 2020;4:e000840. doi:10.1136/bmjpo-2020-000840
Open access
2 Ofce on Smoking and Health - National Center for Chronic Disease
Prevention and Health Promotion. Outbreak of lung injury associated
with the use of e- cigarette, or Vaping, products, 2020. Available:
https://www. cdc. gov/ tobacco/ basic_ information/ e- cigarettes/ severe-
lung- disease. html [Accessed 22 Apr 2020].
3 Chadi N, Do M, Beno S, etal. Vaping- related illness and injury.
Ottawa, ON, 2019. https://www. cpsp. cps. ca/ uploads/ surveys/ Survey-
Vaping- related- illness- and- injury. pdf. (accessed 27 Mar 2020).
4 Jenssen BP, Walley SC, Section on Tobacco Control. E- Cigarettes
and similar devices. Pediatrics 2019;143:e20183652.
5 Health Canada. Vaping- associated lung illness, 2020. Available:
https://www. canada. ca/ en/ public- health/ services/ diseases/ vaping-
pulmonary- illness. html [Accessed 22 Apr 2020].
6 Nguyen HV. Association of Canada’s Provincial Bans on Electronic
Cigarette Sales to Minors With Electronic Cigarette Use Among
Youths. JAMA Pediatr 2020;174:e193912.
on August 2, 2024 by guest. Protected by copyright.http://bmjpaedsopen.bmj.com/bmjpo: first published as 10.1136/bmjpo-2020-000840 on 19 October 2020. Downloaded from